Cargando…

Metabolome in progression to Alzheimer's disease

Mild cognitive impairment (MCI) is considered as a transition phase between normal aging and Alzheimer's disease (AD). MCI confers an increased risk of developing AD, although the state is heterogeneous with several possible outcomes, including even improvement back to normal cognition. We soug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orešič, M, Hyötyläinen, T, Herukka, S-K, Sysi-Aho, M, Mattila, I, Seppänan-Laakso, T, Julkunen, V, Gopalacharyulu, P V, Hallikainen, M, Koikkalainen, J, Kivipelto, M, Helisalmi, S, Lötjönen, J, Soininen, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309497/ https://www.ncbi.nlm.nih.gov/pubmed/22832349 http://dx.doi.org/10.1038/tp.2011.55

Ejemplares similares

Metabolome in schizophrenia and other psychotic disorders: a general population-based study
por: Orešič, Matej, et al.
Publicado: (2011)

Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2016)

Improved Classification of Alzheimer's Disease Data via Removal of Nuisance Variability
por: Koikkalainen, Juha, et al.
Publicado: (2012)

Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease
por: Wolz, Robin, et al.
Publicado: (2011)

Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer’s Disease
por: Jääskeläinen, Olli, et al.
Publicado: (2020)

Structural MRI in Frontotemporal Dementia: Comparisons between Hippocampal Volumetry, Tensor-Based Morphometry and Voxel-Based Morphometry
por: Muñoz-Ruiz, Miguel Ángel, et al.
Publicado: (2012)

Serum Lipidomics Meets Cardiac Magnetic Resonance Imaging: Profiling of Subjects at Risk of Dilated Cardiomyopathy
por: Sysi-Aho, Marko, et al.
Publicado: (2011)

Normalization method for metabolomics data using optimal selection of multiple internal standards
por: Sysi-Aho, Marko, et al.
Publicado: (2007)

Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer's disease
por: Orešič, Matej, et al.
Publicado: (2010)

Metabolic Regulation in Progression to Autoimmune Diabetes
por: Sysi-Aho, Marko, et al.
Publicado: (2011)

Integrated Model of Metabolism and Autoimmune Response in β-Cell Death and Progression to Type 1 Diabetes
por: Marinković, Tijana, et al.
Publicado: (2012)

Gender-dependent progression of systemic metabolic states in early childhood
por: Nikkilä, Janne, et al.
Publicado: (2008)

Targeted Serum Metabolite Profiling Identifies Metabolic Signatures in Patients with Alzheimer's Disease, Normal Pressure Hydrocephalus and Brain Tumor
por: Orešič, Matej, et al.
Publicado: (2018)

Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool
por: Liu, Yawu, et al.
Publicado: (2013)

Cord Serum Lipidome in Prediction of Islet Autoimmunity and Type 1 Diabetes
por: Orešič, Matej, et al.
Publicado: (2013)

The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer's Disease, and Frontotemporal Dementia
por: Cajanus, Antti, et al.
Publicado: (2019)

Plasma Aβ42 and Aβ40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study
por: Seppälä, T T, et al.
Publicado: (2010)

42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Hyötyläinen, Tuulia, et al.
Publicado: (2018)

New Insights into Alzheimer's Disease Progression: A Combined TMS and Structural MRI Study
por: Niskanen, Eini, et al.
Publicado: (2011)

Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study
por: Pietiläinen, Kirsi H., et al.
Publicado: (2007)

Characterization of microbial metabolism of Syrah grape products in an in vitro colon model using targeted and non-targeted analytical approaches
por: Aura, Anna-Marja, et al.
Publicado: (2012)

Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study
por: Hallikainen, Ilona, et al.
Publicado: (2012)

Development of a Late-Life Dementia Prediction Index with Supervised Machine Learning in the Population-Based CAIDE Study
por: Pekkala, Timo, et al.
Publicado: (2016)

Genetic Loci Associated with Alzheimer’s Disease and Cerebrospinal Fluid Biomarkers in a Finnish Case-Control Cohort
por: Elias-Sonnenschein, Lyzel S., et al.
Publicado: (2013)

A novel CT-based automated analysis method provides comparable results with MRI in measuring brain atrophy and white matter lesions
por: Kaipainen, Aku L, et al.
Publicado: (2021)

Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study
por: Bruun, Marie, et al.
Publicado: (2019)

Metabolomics Profiling As a Diagnostic Tool in Severe Traumatic Brain Injury
por: Posti, Jussi P., et al.
Publicado: (2017)

Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis
por: Suvitaival, T, et al.
Publicado: (2016)

The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy
por: Jørgenrud, Benedicte, et al.
Publicado: (2015)

Detection of Molecular Paths Associated with Insulitis and Type 1 Diabetes in Non-Obese Diabetic Mouse
por: Lindfors, Erno, et al.
Publicado: (2009)

Neurofilament light level correlates with brain atrophy, and cognitive and motor performance
por: Kartau, Marge, et al.
Publicado: (2023)

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes
por: Orešič, Matej, et al.
Publicado: (2008)

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
por: Jendle, J., et al.
Publicado: (2021)

Detecting Amyloid Positivity in Elderly With Increased Risk of Cognitive Decline
por: Pekkala, Timo, et al.
Publicado: (2020)

Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort
por: Muurling, Marijn, et al.
Publicado: (2020)

A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle
por: Laaksonen, Reijo, et al.
Publicado: (2006)

Multimodal Preventive Trial for Alzheimer’s Disease: MIND-ADmini Pilot Trial Study Design and Progress
por: Sindi, S., et al.
Publicado: (2022)

cCOG: A web‐based cognitive test tool for detecting neurodegenerative disorders
por: Rhodius‐Meester, Hanneke F.M., et al.
Publicado: (2020)

Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity
por: Lanzon, Borja, et al.
Publicado: (2021)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4
por: Andreasson, U, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h265n3r5d2iv7kp0a5mj7m2b3l